RUC-4: A Novel IIb 3 Antagonist for Prehospital Therapy of Myocardial Infarction

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.114.303724
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Ion Therapy: A Novel Strategy for Acute Myocardial Infarction

Advanced Science
Materials ScienceGeneticsMolecular BiologyBiochemistryEngineeringChemical EngineeringMedicineAstronomyPhysics
2018English

Prehospital Diagnosis and Management of Acute Myocardial Infarction

2018English

Neighborhood Income, Health Insurance, and Prehospital Delay for Myocardial Infarction

Archives of Internal Medicine
2008English

Effects of Myocardial Infarction in Past History and Preinfarction Syndrome on Duration of Prehospital Stage of Acute Myocardial Infarction

Complex Issues of Cardiovascular Diseases
2016English

Myocardial Infarction After Tetraethylammonium Therapy

BMJ
1950English

Unmet Needs in the Management of Acute Myocardial Infarction: Role of Novel Protease-Activated Receptor-1 Antagonist Vorapaxar

Vascular Health and Risk Management
2014English

Tiapamil, a New Calcium Antagonist: Hemodynamic Effects in Patients With Acute Myocardial Infarction

Circulation
Cardiovascular MedicinePhysiologyCardiology
1985English

A Milestone for Myocardial Infarction.

BMJ
1988English

Patients’ and Ambulance Service Clinicians’ Experiences of Prehospital Care for Acute Myocardial Infarction and Stroke: A Qualitative Study: Table 1

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy